2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
…, E Gromnica‐Ihle, M Baleva, M Mosca… - … : Official Journal of …, 2002 - Wiley Online Library
Objective To analyze the clinical and immunologic manifestations of antiphospholipid
syndrome (APS) in a large cohort of patients and to define patterns of disease expression. …
syndrome (APS) in a large cohort of patients and to define patterns of disease expression. …
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
RF Van Vollenhoven, M Mosca, G Bertsias… - Annals of the …, 2014 - ard.bmj.com
The principle of treating-to-target has been successfully applied to many diseases outside
rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic …
rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic …
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
M Mosca, C Tani, M Aringer, S Bombardieri… - Annals of the …, 2010 - ard.bmj.com
Objectives To develop recommendations for monitoring patients with systemic lupus
erythematosus (SLE) in clinical practice and observational studies and to develop a standardised …
erythematosus (SLE) in clinical practice and observational studies and to develop a standardised …
Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices
B Griffiths, M Mosca, C Gordon - Best practice & research Clinical …, 2005 - Elsevier
The assessment of disease activity in systemic lupus erythematosus (SLE) is a task faced by
clinicians in every day care, but it is also required for clinical research and in randomised …
clinicians in every day care, but it is also required for clinical research and in randomised …
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Our objective was to update the EULAR recommendations for the management of systemic
lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic …
lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic …
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
…, DA Lynch, EL Matteson, M Mosca… - European …, 2015 - Eur Respiratory Soc
Many patients with an idiopathic interstitial pneumonia (IIP) have clinical features that suggest
an underlying autoimmune process but do not meet established criteria for a connective …
an underlying autoimmune process but do not meet established criteria for a connective …
EULAR recommendations for the management of antiphospholipid syndrome in adults
…, J King, F Marchiori, PL Meroni, M Mosca… - Annals of the …, 2019 - ard.bmj.com
The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …
[HTML][HTML] EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with …
…, F Marchiori, PL Meroni, M Mosca… - Annals of the …, 2017 - ard.bmj.com
Objectives Develop recommendations for women9s health issues and family planning in
systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Methods …
systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Methods …
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
…, PGD De Groot, M Baleva, M Mosca… - Annals of the …, 2015 - ard.bmj.com
Objectives To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid
syndrome (APS) during a 10-year-follow-up period and to compare the frequency of …
syndrome (APS) during a 10-year-follow-up period and to compare the frequency of …